ONMD - NASDAQ
OneMedNet Corporation
$0.93
-40%OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. The company is based in Eden Prairie, Minnesota.
At a Glance
Live SnapshotOneMedNet Corporation Profit Bridge
Profitability Analysis
Gross Margin
Negative gross margin indicates the company is losing money on each sale—unsustainable long-term.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.
OneMedNet Corporation Income Statement
ONMD • NASDAQ
| OneMedNet Corporation Income Statement | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
REVENUE | |||||
643K | 1M | 1.2M | 1.1M | 824K | |
GROSS PROFIT | |||||
(924K) | (1.2M) | (1.5M) | (1.2M) | (611.7K) | |
-281K | -129K | -360K | -113.4K | 212.4K | |
OPERATING INCOME | |||||
(9.3M) | (6.7M) | (7.4M) | (2.6M) | (3.1M) | |
(7.9M) | (4.7M) | (13.8M) | (1.8M) | (2.4M) | |
(1.5M) | (2.1M) | (1.6M) | (642.8K) | (307.3K) | |
-9.6M | -6.9M | -7.7M | -2.7M | -2.9M | |
PRE-TAX INCOME | |||||
(147K) | (11K) | (403.3K) | (195.4K) | (0.0) | |
-147K | -11K | -403.3K | -195.4K | 193.5K | |
(0.0) | (0.0) | -8.1M | (152.5K) | (454.6K) | |
-522K | -26.9M | -22.7M | -230.3K | 110.6K | |
-10.1M | -33.8M | -30.4M | -2.9M | -2.8M | |
NET INCOME | |||||
(2K) | (18K) | (17K) | (0.0) | (0.0) | |
-10.1M | -33.8M | -30.5M | -2.9M | -2.8M |
SEC Filings
ONMD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2025 Q3 Q3 | November 14, 2025 | September 30, 2025 | 2025 | |
DEF 14A DEF 14A 2025 N/A | November 07, 2025 | November 07, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 07, 2025 | November 06, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 09, 2025 | October 08, 2025 | 2025 | |
8-K 8-K 2025 N/A | September 15, 2025 | September 11, 2025 | 2025 | |
10-Q 10-Q 2025 Q2 Q2 | August 13, 2025 | June 30, 2025 | 2025 | |
S-1/A S-1/A (Amended) N/A | July 14, 2025 | July 14, 2025 | ||
8-K 8-K 2025 N/A | July 11, 2025 | July 11, 2025 | 2025 | |
8-K 8-K 2025 N/A | July 08, 2025 | July 08, 2025 | 2025 | |
S-1/A S-1/A (Amended) N/A | June 25, 2025 | June 25, 2025 |
Related Guides
Continue your ONMD research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.